The Claim
Eicosapentaenoic acid (EPA) produces a greater reduction in inflammatory markers compared to docosahexaenoic acid (DHA) in humans.
What the research says
Challenges is higher
Challenge is ahead, but a single strong supporting study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In humans, eicosapentaenoic acid (EPA) reduces inflammation more than docosahexaenoic acid (DHA).
See the scientific wording
Eicosapentaenoic acid (EPA) exerts a stronger anti-inflammatory effect than docosahexaenoic acid (DHA) in humans.
DHA gets incorporated into cell membranes and is turned into molecules that actively stop inflammation by blocking immune cells from overreacting and cleaning up damaged tissue. It also signals fat cells to release a hormone that reduces liver inflammation and improves cholesterol handling. EPA does not produce these molecules as effectively, so DHA reduces inflammation markers more strongly.
What the research says
1 studyThe study found that DHA, not EPA, did a better job at lowering key inflammation markers in people. So, the idea that EPA is stronger at reducing inflammation is not supported by this research.
Related videos
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.
